Quest Partners LLC Recursion Pharmaceuticals, Inc. Transaction History
Quest Partners LLC
- $737 Billion
- Q2 2024
A detailed history of Quest Partners LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 24,219 shares of RXRX stock, worth $143,376. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,219
Previous 15,868
52.63%
Holding current value
$143,376
Previous $158 Million
14.82%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
285Shares Held
236MCall Options Held
972KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl28.1MShares$167 Million1.92% of portfolio
-
Baillie Gifford & CO26.6MShares$157 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$128 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$102 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$91.1 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.07B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...